These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8174312)

  • 1. Factors affecting compliance with preventive treatment for tuberculosis at Mistassini Lake, Quebec, Canada.
    Rideout M; Menzies R
    Clin Invest Med; 1994 Feb; 17(1):31-6. PubMed ID: 8174312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance.
    Liam CK; Lim KH; Wong CM; Tang BG
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):300-9. PubMed ID: 10206500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians.
    Mori MA; Leonardson G; Welty TK
    Arch Intern Med; 1992 Mar; 152(3):547-50. PubMed ID: 1546917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with compliance in treatment of tuberculosis.
    Menzies R; Rocher I; Vissandjee B
    Tuber Lung Dis; 1993 Feb; 74(1):32-7. PubMed ID: 8495018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.
    Fallab-Stubi CL; Zellweger JP; Sauty A; Uldry C; Iorillo D; Burnier M
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):525-30. PubMed ID: 9661817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS).
    O'Boyle SJ; Power JJ; Ibrahim MY; Watson JP
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):307-12. PubMed ID: 11936739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians.
    Amira CO; Okubadejo NU
    Niger Postgrad Med J; 2007 Dec; 14(4):325-9. PubMed ID: 18163143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive antituberculosis chemotherapy in 250 patients of the antituberculosis outpatient clinic in Lausanne].
    Racine-Perreaud E; Zellweger JP
    Schweiz Med Wochenschr; 1994 Apr; 124(17):705-11. PubMed ID: 8202667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of tuberculosis contacts investigation and treatment, especially of preventive therapy in infants and young children].
    Kondo S; Ito M
    Kekkaku; 2003 Nov; 78(11):677-82. PubMed ID: 14672044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings].
    Yoshiyama T
    Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients.
    Naing NN; D'Este C; Isa AR; Salleh R; Bakar N; Mahmod MR
    Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):369-82. PubMed ID: 11556591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness.
    MacIntyre CR; Ansari MZ; Carnie J; Hart WG
    Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive chemotherapy for tuberculous infection. Arguments against].
    Zellweger JP
    Schweiz Med Wochenschr; 1993 Feb; 123(5):158-60. PubMed ID: 8438137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany].
    Schaberg T; Hauer B; Haas WH; Hohlfeld J; Kropp R; Loddenkemper R; Loytved G; Magdorf K; Rieder HL; Sagebiel D
    Pneumologie; 2004 Apr; 58(4):255-70. PubMed ID: 15098162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.